Registry for granulomatous mastitis
Part of Digestive system, Genetic & congenital, Lungs & breathing, Skin, Women’s health & pregnancy clinical trials.
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with a rare type of breast inflammation called idiopathic granulomatous mastitis (or a specific subtype).
- This diagnosis must have been made by a tissue sample (biopsy) or after surgery.
- The first diagnosis must have happened on or after January 1, 2015.
- You need to be at least 18 years old.
- Your mastitis must not be caused by other conditions like tuberculosis, sarcoidosis, a fungal or parasitic infection, or a reaction to a foreign object.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different surgical methods for treating granulomatous mastitis, a rare inflammatory breast condition. It aims to find which approach works best for patients who can safely have surgery.
This study looks at different ways to treat granulomatous lobular mastitis (GLM), a type of breast inflammation that is not an infection. The goal is to find which treatment works best for people with this condition.
This trial tests tocilizumab, a medication that reduces inflammation, for granulomatous lobular mastitis (GLM)—a rare, persistent breast inflammation. If your GLM hasn't responded to steroid therapy or you can't tolerate steroids, this study may help reduce inflammation and symptoms.
This study compares two common treatments—antibiotics and steroids—to see which works better for a rare breast inflammation condition called granulomatous lobular mastitis (GLM). It aims to find the most effective and safe option for women with this condition.
This trial tests whether a steroid injection directly into the breast can help treat idiopathic granulomatous mastitis (IGM), a rare non-cancerous inflammatory breast condition. If you have been diagnosed with IGM, this study offers a potentially less invasive treatment option.
This trial compares two treatments—steroids (prednisolone) and methotrexate—for a chronic inflammatory breast condition. It aims to find which option works better with fewer side effects.
Hear when a new Idiopathic Granulomatous Mastitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.